International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Integration of Rapid Toxicological and Endocrine Disorder Screening Using LC-MS/MS to Improve Maternal and Infant Health Outcomes
| Author(s) | Binata Shrestha, Sujan Koju, Ekata Shrestha |
|---|---|
| Country | United States |
| Abstract | Peripartum periods are highly susceptible to both xenobiotic toxin exposure and endocrine abnormalities. Traditional testing uses independent immunoassays for toxicological and endocrine assessment, which often leads to delay, cross-reactivity, and undetected coexisting pathologies. The use of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) allows for parallel and highly specific measurements of toxicological and endocrine markers through a single assay. This literature review will explore the epidemiology of toxicant exposure and endocrine dysfunction during pregnancy, compare LC-MS/MS and traditional immunoassays, assess evidence for dual-domain screening, and examine implementation issues. The LC-MS/MS had better analytical capabilities with sensitivity of 90-99% and specificity of 95-99.5% as opposed to the immunoassays with sensitivity of 68-92% and specificity of 65-94%. Detection limits were also 10-1000 times lower for important analytes including synthetic opioids, endocrine disruptors, and trace steroids. The integrated screening allowed detection of both toxicological and endocrine disorders in 15-22% of high risk pregnancies. Early detection of abnormal conditions using the LC-MS/MS test was linked with decreases in NICU admissions, preterm births, neonatal withdrawal syndromes, and thyroid status misclassifications. Cost-effectiveness analysis showed favorable results at moderate to high volumes. The LC-MS/MS screening is more clinically and analytically effective than the traditional siloed testing. |
| Keywords | LC-MS/MS; tandem mass spectrometry; maternal toxicology; neonatal outcomes; prenatal screening; biomarker quantification; obstetric pharmacology |
| Field | Biology |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-07-31 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i04.84176 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals